Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases

Recent Advances in Understanding Hormonal Therapy Resistant Prostate Cancer

(2010) K.V. Donkena et al.   CURRENT CANCER DRUG TARGETS

Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy

(2009) Michael Giesing et al.   BJU INTERNATIONAL

Circulating Prostate Tumor Cells Detected by Reverse Transcription-PCR in Men with Localized or Castration-Refractory Prostate Cancer: Concordance with CellSearch Assay and Association with Bone Metastases and with Survival

(2009) P. Helo et al.   CLINICAL CHEMISTRY

Prevalence of Skeletal Complications and Their Impact on Survival of Hormone Refractory Prostate Cancer Patients in Japan

(2009) Takamitsu Inoue et al.   UROLOGY

Androgen regulation of the androgen receptor coregulators

(2008) Alfonso Urbanucci et al.   BMC CANCER

Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells

(2008) Chen-Lin Hsieh et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate Cancer

(2008) John W. Davis et al.   JOURNAL OF UROLOGY

Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence

(2008) Jason M. D'Antonio et al.   PROSTATE